Cosmetovigilance Studies to Assess the Safety of Cosmetic Therapy in Hair Segments and Non-Laser Skin Treatments

February 2026 in “ International Journal of Basic & Clinical Pharmacology ”

Ramya C. V., Mekkanti Manasa Rekha, Shobha Rani R H

cosmetovigilance hair rejuvenation QR678 platelet-rich plasma growth factor concentrate adverse drug reactions non-laser skin treatments comorbidities diabetes PRP GFC

TLDR Cosmetovigilance and clinical pharmacists can enhance safety in cosmetic treatments, especially for those with diabetes.

This study assessed the safety of cosmetic therapies using a cosmetovigilance approach, focusing on hair rejuvenation and non-laser skin treatments in 410 patients. Hair therapies like QR678, PRP, and GFC showed a significant association with adverse drug reactions (ADRs), while non-laser skin treatments did not. Comorbidities, especially diabetes, were strongly linked to both the incidence and severity of ADRs. The study concludes that integrating cosmetovigilance practices and involving clinical pharmacists can improve patient safety and optimize treatment protocols.

View this study on ijbcp.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

research Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia

3 citations , May 2017 in “Dermatologic Surgery”

PRP may help treat female hair loss, but more research needed.

Similar Research

5 / 16 results

Technological Advances in Anti-Hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation

research Technological Advances in Anti-Hair Loss and Hair Regrowth Cosmeceuticals: Mechanistic Breakthroughs and Industrial Prospects Driven by Multidisciplinary Collaborative Innovation

August 2025 in “Aesthetic Plastic Surgery”

Collaboration and innovation are key to developing effective, safe hair loss treatments.

research Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Retrospective Cohort Study of 90 Patients

June 2017 in “Journal of the American Academy of Dermatology”

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

research Cosmetovigilance in the Netherlands: Overview of the Period 2009-2014

February 2015 in “Rivm (National Institute for Public Health and the Environment)”

Cosmetics in the Netherlands were mostly safe but sometimes caused allergic reactions, leading to potential bans on certain ingredients.

research Cosmetology of Black Skin

January 2023 in “Annales de dermatologie et de vénéréologie, FMC”

Black skin requires specific cosmetic practices, which can sometimes cause skin issues due to product misuse, and there's a need for better regulations in sub-Saharan Africa.

research Hair Cosmetics for the Hair Loss Patient

1 citations , October 2021 in “Indian Journal of Plastic Surgery/Indian journal of plastic surgery”

Proper hair care and safe use of hair products are crucial for those with hair loss.